Phase 2 trial uses hyperpolarized 129Xe MRI to study airway remodeling in obese asthma

A phase 2 clinical trial proposed using 3D functional imaging with hyperpolarized 129Xe MRI and single-cell RNA sequencing to study mechanisms driving regional airway remodeling and fibrosis. The study enrolled 49 obese asthma subjects, with a planned follow-up of 46 months. The primary outcomes were defined as the percentage of neutrophils and eosinophils in peripheral blood.

No results for the primary or any secondary outcomes are reported. The effect size, absolute numbers, p-values, and direction of findings are all listed as not reported. The study design focused on comparing imaging and sequencing data between obese asthma subjects and preclinical models.

Safety and tolerability data, including adverse events, serious adverse events, and discontinuations, are not reported. Key limitations of the available evidence include the complete absence of trial results and the lack of reported comparator groups or setting details.

The practice relevance of this approach cannot be assessed without clinical trial results. Funding sources and conflicts of interest are also not reported. This remains a proposed methodological study for investigating disease mechanisms rather than an intervention with established efficacy or safety.

Researchers conducted a clinical trial to better understand asthma in people who also have obesity. They used an advanced imaging technique called hyperpolarized 129Xe MRI, which creates detailed 3D pictures of the lungs, along with genetic analysis of individual cells. The goal was to study the mechanisms that might cause airway scarring and structural changes in this specific group of patients. The trial involved 49 people with both asthma and obesity, and researchers followed them for about 46 months. This was a Phase 2 trial, which means it was still in the middle stages of testing. The study design was focused on understanding the biology of the condition rather than testing a new treatment. The main reason to be careful is that the source material only describes the study's plan and methods. No actual results from this trial—like what the imaging or genetic tests showed—have been made public. We don't know if the techniques revealed new information or if there were any safety concerns with the procedures. Because no findings are reported, this research should be viewed as work in progress. It represents scientists trying to build better tools to study a complex health issue, but it doesn't yet offer any new insights for patients or doctors.